...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: USA ZHCLF investors

So who issued the 63 m shares, ZCC or ZEL. Does ZCC issue the shares and give the money to ZEL or ZEL says "I need operating cash and am selling X number shares".

Share
New Message
Please login to post a reply